Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Lilly claims antitumor benzoylsulfonamides and sulfonylbenzamidines

Jan. 28, 2003

rHu-KGF reduces severe oral mucositis in bone marrow transplant patients

Jan. 27, 2003

Antiinflammatory effects of omega-3 fatty acids

Jan. 24, 2003

Velcade NDA submitted for multiple myeloma

Jan. 24, 2003

Yamanouchi reports novel VEGF inhibitors

Jan. 24, 2003

RK-0202 enters phase II evaluation in oral mucositis

Jan. 23, 2003

CYC-202 enters phase IIa trials in breast and lung cancers

Jan. 22, 2003

E.U. approves Taxotere in combination with cisplatin for first-line NSCLC treatment

Jan. 22, 2003

Pierre Fabre presents novel inhibitors of protein prenyltransferases

Jan. 22, 2003

Agouron discovers novel nonpeptide GnRH antagonists

Jan. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...